Estrogen-induced acute pancreatitis: A case report and literature review
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Estrogens are commonly used in gynecologic area, such as oral contraception, hormone replacement therapy, and in vitro fertilization-embryo transfer. Although estrogen is a common cause of acute drug-induced pancreatitis, there has been paucity of report in Korea. Clinical course of estrogen-induced acute pancreatitis is usually mild to moderate, but fetal case can occur. In addition, there can be a latency from the first administration to the symptom. Therefore, physicians should consider the possibility of the disease when a woman taking estrogen or previous history of taking estrogen presents with acute abdominal pain. Here, we report a case of estrogen-induced acute pancreatitis that occurred during the preparation for embryo transfer.
Abstract
Estrogens are commonly used in gynecologic area, such as oral contraception, hormone replacement therapy, and in vitro fertilization-embryo transfer. Although estrogen is a common cause of acute drug-induced pancreatitis, there has been paucity of report in Korea. Clinical course of estrogen-induced acute pancreatitis is usually mild to moderate, but fetal case can occur. In addition, there can be a latency from the first administration to the symptom. Therefore, physicians should consider the possibility of the disease when a woman taking estrogen or previous history of taking estrogen presents with acute abdominal pain. Here, we report a case of estrogen-induced acute pancreatitis that occurred during the preparation for embryo transfer.
참고문헌 (15)
- Badalov N, "Drug-induced acute pancreatitis: an evidencebased review", Clin Gastroenterol Hepatol, 5, pp.648~661 (2007)
- Abraham M, "Hypertriglyceridemic pancreatitis caused by the oral contraceptive agent estrostep", J Intensive Care Med, 30, pp.303~307 (2015)
- Lee J, "Hypertriglyceridemia-induced pancreatitis created by oral estrogen and in vitro fertilization ovulation induction", J Clin Lipidol, 2, pp.63~66 (2008)
- Oskarsson V, "Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a prospective cohort study", CMAJ, 186, pp.338~344 (2014)
- Perego E, "Estrogen-induced severe acute pancreatitis in a male", JOP, 5, pp.353~356 (2004)
- Gan SI, "Hypertriglyceridemia-induced pancreatitis: a case-based review", World J Gastroenterol, 12, pp.7197~7202 (2006)
- Yadav D, "Issues in hyperlipidemic pancreatitis", J Clin Gastroenterol, 36, pp.54~62 (2003)
- Nitsche CJ, "Drug induced pancreatitis", Best Pract Res Clin Gastroenterol, 24, pp.143~155 (2010)
- Vrablik M, "Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins", Metabolism, 57, pp.1088~1092 (2008)
- Davar R, "A comparison of the effects of transdermal estradiol and estradiol valerate on endometrial receptivity in frozenthawed embryo transfer cycles: a randomized clinical trial", J Reprod Infertil, 17, pp.97~103 (2016)
- Madero S, "Endometrial preparation: effect of estrogen dose and administration route on reproductive outcomes in oocyte donation cycles with fresh embryo transfer", Hum Reprod, 31, pp.1755~1764 (2016)
- Dal Prato L, "Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist", Fertil Steril, 77, pp.956~960 (2002)
- Bank S, "Case reports. Hyperlipaemic pancreatitis and the pill", Postgrad Med J, 46, pp.576~578 (1970)
- Davidoff F, "Marked hyperlipidemia and pancreatitis associated with oral contraceptive therapy", N Engl J Med, 289, pp.552~555 (1973)
- Ruman J, "Severe hypertriglyceridemia and pancreatitis following hormone replacement prior to cryothaw transfer", J Assist Reprod Genet, 19, pp.94~97 (2002)